{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-281247","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.508428+00:00","generated_at":"2026-06-22T01:53:24.262805+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cytek Q3 revenue $40.5M (+18% YoY); net income $1.6M; guides FY near high end of $160-168M","bullets":["Revenue $40.5M (+18% YoY); gross margin improved to 66.4% from 61.9%.","Net income $1.6M (vs $1.4M); adjusted EBITDA $7.3M (vs $5.5M).","FY2022 revenue guidance reaffirmed closer to high end of $160M-$168M range.","Appointed Chris Williams as Chief Operating Officer during the quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-281247","json":"https://secwatch.observer/filing/0001193125-22-281247.json","markdown":"https://secwatch.observer/filing/0001193125-22-281247.md","text":"https://secwatch.observer/filing/0001193125-22-281247.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522281247/0001193125-22-281247-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522281247/d384960d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T01:53:24.262805+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6cb6e5b97c20d32857e378d535a230441455f521","claim":"Cytek Biosciences, Inc. reported the third quarter ended September 30, 2022 results: revenue $40.5 million, net income $1.6 million. Guidance reaffirmed.","evidence_excerpt":"Total revenue was $40.5 million for the third quarter, representing an 18% increase over the corresponding quarter of 2021","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522281247/0001193125-22-281247-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Revenue","value":"$40.5 million"},{"label":"Net income","value":"$1.6 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}